Assessing novel partner antimicrobials to protect ceftriaxone against gonococcal resistance: An in vitro evaluation.
Saïd AbdellatiZina GestelsYuliia BaranchykTessa de BlockDorien Van Den BosscheDe Baetselier IrithManoharan-Basil Santhini SheebaChris Richard KenyonPublished in: International journal of STD & AIDS (2024)
The low MICs of zoliflodacin and pristinamycin for the three ceftriaxone-resistant strains suggest that these antimicrobials could be used as partner drugs with ceftriaxone to reduce the probability of ceftriaxone resistance spreading in areas with a high prevalence of ceftriaxone resistance.